Medical Research
(H30)
IRS Verified
DX Registered
GLIOBLASTOMA FOUNDATION INC
CharityAI™ Score
Not yet evaluated
Mission Statement
To modify the current standard of care for glioblastoma by replacing radiation and chemotherapy with targeted small molecule therapies that prolong survival and increase quality of life.
Financial Overview — FY 2022
$1.5M
Total Revenue
$854K
Total Expenses
N/A
Net Assets
5
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$193K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2022 | $1.5M | $854K | N/A | — | 5 |
| 2021 | $1.3M | $703K | N/A | — | 5 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.